These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10800753)

  • 1. Behavioral effects of intra-nigral microinjections of manganese chloride: interaction with nitric oxide.
    Ponzoni S; Guimarães FS; Del Bel EA; Garcia-Cairasco N
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):307-25. PubMed ID: 10800753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of manganese from the rat substantia nigra following intra-nigral microinjections.
    Ponzoni S; Gaziri LC; Britto LR; Barreto WJ; Blum D
    Neurosci Lett; 2002 Aug; 328(2):170-4. PubMed ID: 12133581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylcyclopentadienyl Manganese Tricarbonyl Alter Behavior and Cause Ultrastructural Changes in the Substantia Nigra of Rats: Comparison with Inorganic Manganese Chloride.
    Zhu QF; Lu LL; Fang YY; Wu J; Huang ZY; Zheng XW; Song HX; Aschner M; Song C; Jiang YM
    Neurochem Res; 2022 Aug; 47(8):2198-2210. PubMed ID: 35513760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of manganese exposure via intracerebral injection on behavioristics and substantia nigra dopaminergic neurons in rats].
    Mo RK; Wang J; Huang JY; Wen QL; Huang JF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Jun; 34(6):406-11. PubMed ID: 27514546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of l-arginine-nitric oxide pathway in anxiolytic-like effects of zinc chloride in rats.
    Navabi SP; Eshagh Harooni H; Moazedi AA; Khajepour L; Fathinia K
    Biomed Pharmacother; 2016 Oct; 83():521-525. PubMed ID: 27442705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese and Vanadium Co-Exposure Induces Severe Neurotoxicity in the Olfactory System: Relevance to Metal-Induced Parkinsonism.
    Ngwa HA; Bargues-Carot A; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism.
    Zhao F; Cai T; Liu M; Zheng G; Luo W; Chen J
    Toxicol Sci; 2009 Jan; 107(1):156-64. PubMed ID: 18836210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the substantia nigra suppresses absences and clonic seizures in audiogenic rats, but not tonic seizures: evidence for seizure specificity of the nigral control.
    Deransart C; Lê-Pham BT; Hirsch E; Marescaux C; Depaulis A
    Neuroscience; 2001; 105(1):203-11. PubMed ID: 11483312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nitric oxide on motor behavior.
    Del Bel EA; Guimarães FS; Bermúdez-Echeverry M; Gomes MZ; Schiaveto-de-souza A; Padovan-Neto FE; Tumas V; Barion-Cavalcanti AP; Lazzarini M; Nucci-da-Silva LP; de Paula-Souza D
    Cell Mol Neurobiol; 2005 Mar; 25(2):371-92. PubMed ID: 16047547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.
    Fernandes A; de Oliveira EF; de Rezende IC; Ponzoni S
    Brain Res; 2010 Mar; 1317():277-85. PubMed ID: 20045397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA.
    Vivó M; Camón L; de Vera N; Martínez E
    Brain Res; 2002 Nov; 955(1-2):104-14. PubMed ID: 12419526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
    Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
    Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
    Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.
    Carman LS; Gage FH; Shults CW
    Brain Res; 1991 Jul; 553(2):275-83. PubMed ID: 1681983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.
    Sengstock GJ; Olanow CW; Dunn AJ; Barone S; Arendash GW
    Exp Neurol; 1994 Nov; 130(1):82-94. PubMed ID: 7529713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
    Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
    Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOS expression in nigral cells after excitotoxic and non-excitotoxic lesion of the pedunculopontine tegmental nucleus.
    González-Hernández T; Abdala P; Rodríguez M
    Eur J Neurosci; 1997 Dec; 9(12):2658-67. PubMed ID: 9517471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase.
    Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
    Neuropharmacology; 1996 Apr; 35(4):459-65. PubMed ID: 8793908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.